Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells

FASEB Journal

Volumn 25, Issue 1, 2011, Pages 192-205

  Wu, Hua ^a   Lin, Yayu ^a   Li, Wengang ^a   Sun, Zhe ^a   Gao, Weiwei ^a   Zhang, Haiping ^a   Xie, Lei ^a   Jiang, Fuquan ^a   Qin, Bin ^a   Yan, Tingdong ^a   Chen, Liqun ^a   Zhao, Yi ^a   Cao, Xihua ^b   Wu, Yin ^b   Lin, Bingzhen ^b   Zhou, Hu ^b   Wong, Alice Sze Tsai ^c   Zhang, Xiao Kun ^a,b   Zeng, Jin Zhang ^a  

^a XIAMEN UNIVERSITY   (China)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AP 1; Bile acid; JNK; PI3K

Indexed keywords

BETA CATENIN; DEOXYCHOLIC ACID; NUCLEAR RECEPTOR NUR77; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN; WNT PROTEIN;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL SURVIVAL; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 78651376455     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-166462     Document Type: Article

References (63)

1. Fahrner, T. J., Carroll, S. L., and Milbrandt, J. (1990) The NGFI-B protein, an inducible member of the thyroid/steroid receptor family, is rapidly modified posttranslationally. Mol. Cell. Biol. 10, 6454-6459
2. Zhang, X. K. (2007) Targeting Nur77 translocation. Expert Opin. Ther. Targets 11, 69-79
3. Zeng, J. Z., and Zhang, X. K. (2007) Nongenomic actions of retinoids: role of Nur77 and RXR in the regulation of apoptosis and inflammation. Anti-Inflamm. Anti-Allergy Agents Med. Chem. 6, 315-331
4. Hazel, T. G., Nathans, D., and Lau, L. F. (1988) A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl. Acad. Sci. U. S. A. 85, 8444-8448
5. Wilson, T. E., Fahrner, T. J., Johnston, M., and Milbrandt, J. (1991) Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252, 1296-1300
6. Philips, A., Lesage, S., Gingras, R., Maira, M. H., Gauthier, Y., Hugo, P., and Drouin, J. (1997) Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 17, 5946-5951
7. Milbrandt, J. (1988) Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1, 183-188
8. Cho, S. D., Yoon, K., Chintharlapalli, S., Abdelrahim, M., Lei, P., Hamilton, S., Khan, S., Ramaiah, S. K., and Safe, S. (2007) Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways. Cancer Res. 67, 674-683
9. Cho, S. D., Lee, S. O., Chintharlapalli, S., Abdelrahim, M., Khan, S., Yoon, K., Kamat, A. M., and Safe, S. (2010) Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol. Pharmacol. 77, 396-404
10. Lee, S. O., Abdelrahim, M., Yoon, K., Chintharlapalli, S., Papineni, S., Kim, K., Wang, H., and Safe, S. H. (2010) Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 70, 6824-6836
11. Kolluri, S. K., Bruey-Sedano, N., Cao, X., Lin, B., Lin, F., Han, Y. H., Dawson, M. I., and Zhang, X. K. (2003) Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell. Biol. 23, 8651-8667
12. Lee, M. O., Kang, H. J., Cho, H., Shin, E. C., Park, J. H., and Kim, S. J. (2001) Hepatitis B virus X protein induced expression of the Nur77 gene. Biochem. Biophys. Res. Commun. 288, 1162-1168
13. Ke, N., Claassen, G., Yu, D. H., Albers, A., Fan, W., Tan, P., Grifman, M., Hu, X., Defife, K., Nguy, V., Meyhack, B., Brachat, A., Wong-Staal, F., and Li, Q. X. (2004) Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res. 64, 8208-8212
14. Liu, J., Zhou, W., Li, S. S., Sun, Z., Lin, B., Lang, Y. Y., He, J. Y., Cao, X., Yan, T., Wang, L., Lu, J., Han, Y. H., Cao, Y., Zhang, X. K., and Zeng, J. Z. (2008) Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. Cancer Res. 68, 8871-8880
15. Thompson, J., and Winoto, A. (2008) During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J. Exp. Med. 205, 1029-1036
16. Rajpal, A., Cho, Y. A., Yelent, B., Koza-Taylor, P. H., Li, D., Chen, E., Whang, M., Kang, C., Turi, T. G., and Winoto, A. (2003) Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor. EMBO J. 22, 6526-6536
17. Zhan, Y., Du, X., Chen, H., Liu, J., Zhao, B., Huang, D., Li, G., Xu, Q., Zhang, M., Weimer, B. C., Chen, D., Cheng, Z., Zhang, L., Li, Q., Li, S., Zheng, Z., Song, S., Huang, Y., Ye, Z., Su, W., Lin, S. C., Shen, Y., and Wu, Q. (2008) Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 4, 548-556
18. Liu, J. J., Zeng, H. N., Zhang, L. R., Zhan, Y. Y., Chen, Y., Wang, Y., Wang, J., Xiang, S. H., Liu, W. J., Wang, W. J., Chen, H. Z., Shen, Y. M., Su, W. J., Huang, P. Q., Zhang, H. K., and Wu, Q. (2010) A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res. 70, 3628-3637
19. Chen, Y. L., Jian, M. H., Lin, C. C., Kang, J. C., Chen, S. P., Lin, P. C., Hung, P. J., Chen, J. R., Chang, W. L., Lin, S. Z., and Harn, H. J. (2008) The induction of orphan nuclear receptor Nur77 expression by n-butylenephthalide as pharmaceuticals on hepatocellular carcinoma cell therapy. Mol. Pharmacol. 74, 1046-1058
20. Wilson, A. J., Arango, D., Mariadason, J. M., Heerdt, B. G., and Augenlicht, L. H. (2003) TR3/Nur77 in colon cancer cell apoptosis. Cancer Res. 63, 5401-5407
21. Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y. H., Cao, X., Dawson, M. I., Reed, J. C., and Zhang, X. K. (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527-540
22. Imray, C. H., Radley, S., Davis, A., Barker, G., Hendrickse, C. W., Donovan, I. A., Lawson, A. M., Baker, P. R., and Neoptolemos, J. P. (1992) Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 33, 1239-1245
23. Markowitz, S. D., Dawson, D. M., Willis, J., and Willson, J. K. (2002) Focus on colon cancer. Cancer Cell 1, 233-236
24. Chiu, B. C., Ji, B. T., Dai, Q., Gridley, G., McLaughlin, J. K., Gao, Y. T., Fraumeni, J. F., Jr., and Chow, W. H. (2003) Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. 12, 201-208
25. Mai, V., Colbert, L. H., Berrigan, D., Perkins, S. N., Pfeiffer, R., Lavigne, J. A., Lanza, E., Haines, D. C., Schatzkin, A., and Hursting, S. D. (2003) Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res. 63, 1752-1755
26. Lin, C. X., Umemoto, A., Seraj, M. J., Mimura, S., and Monden, Y. (2001) Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon. Cancer Lett. 169, 121-126
27. Flynn, C., Montrose, D. C., Swank, D. L., Nakanishi, M., Ilsley, J. N., and Rosenberg, D. W. (2007) Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol. Carcinog. 46, 60-70
28. Bienz, M., and Clevers, H. (2000) Linking colorectal cancer to Wnt signaling. Cell 103, 311-320
29. Van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A. P., Tjon-Pon-Fong, M., Moerer, P., van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., and Clevers, H. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250
30. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480
31. MacDonald, B. T., Tamai, K., and He, X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26
32. Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., and Lu, Z. (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229
33. Pai, R., Tarnawski, A. S., and Tran, T. (2004) Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell 15, 2156-2163
34. Mimori-Kiyosue, Y., and Tsukita, S. (2001) Where is APC going? J. Cell. Biol. 154, 1105-1109
35. Phelps, R. A., Chidester, S., Dehghanizadeh, S., Phelps, J., Sandoval, I. T., Rai, K., Broadbent, T., Sarkar, S., Burt, R. W., and Jones, D. A. (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137, 623-634
36. Blum, C. A., Xu, M., Orner, G. A., Fong, A. T., Bailey, G. S., Stoner, G. D., Horio, D. T., and Dashwood, R. H. (2001) beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f] quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 22, 315-320
37. Hirose, Y., Kuno, T., Yamada, Y., Sakata, K., Katayama, M., Yoshida, K., Qiao, Z., Hata, K., Yoshimi, N., and Mori, H. (2003) Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24, 107-111
38. Hashizume, H., Falcon, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D., Bready, J. V., Oliner, J. D., and McDonald, D. M. (2010) Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res. 70, 2213-2223
39. Stein, U., Arlt, F., Walther, W., Smith, J., Waldman, T., Harris, E. D., Mertins, S. D., Heizmann, C. W., Allard, D., Birchmeier, W., Schlag, P. M., and Shoemaker, R. H. (2006) The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131, 1486-1500
40. Ikari, A., Sanada, A., Okude, C., Sawada, H., Yamazaki, Y., Sugatani, J., and Miwa, M. (2010) Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J. Cell. Physiol. 222, 481-487
41. Eferl, R., and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
42. Silvers, A. L., Bachelor, M. A., and Bowden, G. T. (2003) The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression. Neoplasia 5, 319-329
43. Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M. I., Reed, J. C., Fontana, J. A., Bost, F., Hobbs, P. D., Zheng, Y., Chen, G. Q., Shroot, B., Mercola, D., and Zhang, X. K. (1998) Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol. Cell. Biol. 18, 4719-4731
44. Uemura, H., Mizokami, A., and Chang, C. (1995) Identification of a new enhancer in the promoter region of human TR3 orphan receptor gene: a member of steroid receptor superfamily. J. Biol. Chem. 270, 5427-5433
45. Yoon, J. K., and Lau, L. F. (1994) Involvement of JunD in transcriptional activation of the orphan receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells. Mol. Cell. Biol. 14, 7731-7743
46. Holla, V. R., Mann, J. R., Shi, Q., and DuBois, R. N. (2006) Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J. Biol. Chem. 281, 2676-2682
47. Jean-Louis, S., Akare, S., Ali, M. A., Mash, E. A., Jr., Meuillet, E., and Martinez, J. D. (2006) Deoxycholic acid induces intracellular signaling through membrane perturbations. J. Biol. Chem. 281, 14948-14960
48. Debruyne, P. R., Bruyneel, E. A., Karaguni, I. M., Li, X., Flatau, G., Muller, O., Zimber, A., Gespach, C., and Mareel, M. M. (2002) Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 21, 6740-6750
49. Raufman, J. P., Shant, J., Guo, C. Y., Roy, S., and Cheng, K. (2008) Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling. J. Cell. Physiol. 215, 538-549
50. Luo, J., Manning, B. D., and Cantley, L. C. (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262
51. Vivanco, I., and Sawyers, C. L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501
52. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., and Davis, R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874
53. Liu, J., Minemoto, Y., and Lin, A. (2004) c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol. Cell. Biol. 24, 10844-10856
54. Jaeschke, A., Karasarides, M., Ventura, J. J., Ehrhardt, A., Zhang, C., Flavell, R. A., Shokat, K. M., and Davis, R. J. (2006) JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 23, 899-911
55. Saadeddin, A., Babaei-Jadidi, R., Spencer-Dene, B., and Nateri, A. S. (2009) The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol. Cancer Res. 7, 1189-1196
56. Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Bodmer, W. F., Moyer, M. P., Riecken, E. O., Buhr, H. J., and Hanski, C. (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 96, 1603-1608
57. Toualbi, K., Guller, M. C., Mauriz, J. L., Labalette, C., Buendia, M. A., Mauviel, A., and Bernuau, D. (2007) Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes. Oncogene 26, 3492-3502
58. Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155, 1033-1038
59. Hlubek, F., Jung, A., Kotzor, N., Kirchner, T., and Brabletz, T. (2001) Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res. 61, 8089-8093
60. Dihlmann, S., Kloor, M., Fallsehr, C., and von Knebel Doeberitz, M. (2005) Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells. Carcinogenesis 26, 1503-1512
61. Gan, X. Q., Wang, J. Y., Xi, Y., Wu, Z. L., Li, Y. P., and Li, L. (2008) Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J. Cell. Biol. 180, 1087-1100
62. Williams, G. T., and Lau, L. F. (1993) Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol. Cell. Biol. 13, 6124-6136
63. Inaoka, Y., Yazawa, T., Uesaka, M., Mizutani, T., Yamada, K., and Miyamoto, K. (2008) Regulation of NGFI-B/Nur77 gene expression in the rat ovary and in Leydig tumor cells MA-10. Mol. Reprod. Dev. 75, 931-939